Migraine Trial, Recruiting NCT06961864 Sponsor: University of Minnesota Condition: Migraine
Back to Migraine

Migraine Trial, Recruiting

NCT06961864
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

For people with Visual Snow Syndrome (VSS):

  • People aged between 18 and 60 years old
  • People with good vision (20/25 or better in each eye), either naturally or with glasses — MRI-compatible glasses will be provided if needed
  • People who are able to follow study instructions
  • People who have been diagnosed with VSS by a specialist, or who experience flickering/static dots across their vision lasting more than 3 months plus at least 2 of these symptoms: seeing images that linger after looking away, visual effects from within the eye itself, trails behind moving objects, sensitivity to light, or difficulty seeing in the dark
  • People who live in Minnesota within 2 hours of the study site

For people without Visual Snow Syndrome (comparison group):

  • People aged between 18 and 60 years old
  • People with good vision (20/25 or better in each eye), either naturally or with glasses — MRI-compatible glasses will be provided if needed
  • People who are able to follow study instructions
  • People who live in Minnesota within 2 hours of the study site

Who may not be able to join:

For people with Visual Snow Syndrome (VSS):

  • People who are not fluent in English or another language for which translation services are available
  • People who have a diagnosed or self-reported intellectual disability
  • People who are currently dependent on substances (other than nicotine), or who experienced drug dependence with tolerance or withdrawal symptoms in the past 12 months
  • People who have used hallucinogenic substances in the past 12 months, or within the 12 months before their VSS symptoms began
  • People with a severe disease affecting the brain or nervous system
  • People who have had a head injury involving a skull fracture or loss of consciousness for more than 30 minutes
  • People with a physical condition that would make it difficult or impossible to carry out or interpret the study assessments (for example, loss of part of the visual field)
  • People under 18 or over 60 years of age
  • For the MRI part of the study: people with metal in the body that has not been approved as safe by the imaging centre's safety committee; people who are pregnant; people with certain conditions that affect blood flow in the brain (confirm with trial site); people with claustrophobia; people unable to lie still for at least one hour; people weighing more than 440 lbs; and, for any CT scan component only, people who have had research-related radiation exposure in the past 12 months
  • People with any vision problem other than VSS or a need for corrective lenses (for example, crossed eyes, lazy eye, or colour blindness)
  • People currently experiencing a psychotic episode

For people without Visual Snow Syndrome (comparison group):

  • People who are not fluent in English or another language for which translation services are available
  • People who have a diagnosed or self-reported intellectual disability
  • People who are currently dependent on substances (other than nicotine), or who experienced drug dependence with tolerance or withdrawal symptoms in the past 12 months
  • People who have used hallucinogenic substances in the past 12 months
  • People with a severe disease affecting the brain or nervous system
  • People who have had a head injury involving a skull fracture or loss of consciousness for more than 30 minutes
  • People with a physical condition that would make it difficult or impossible to carry out or interpret the study assessments (for example, loss of part of the visual field)
  • People under 18 or over 60 years of age
  • For the MRI part of the study: people with metal in the body that has not been approved as safe by the imaging centre's safety committee; people who are pregnant; people with certain conditions that affect blood flow in the brain (confirm with trial site); people with claustrophobia; people unable to lie still for at least one hour; people weighing more than 440 lbs; and, for any CT scan component only, people who have had research-related radiation exposure in the past 12 months
  • People with any vision problem or need for corrective lenses (for example, crossed eyes, lazy eye, or colour blindness)
  • People who have ever had VSS symptoms or a VSS diagnosis
  • People currently experiencing a psychotic episode

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 27 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Michael-Paul Schallmo, Ph.D., University of Minnesota, Department of Psychiatry and Behavioral Sciences

Phone: (612) 273-9130

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Registry
ClinicalTrials.gov
Start date
11 April 2025
Est. completion
31 March 2030

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Psychophysical Adaptation Task Performance; Functional Magnetic Resonance Imaging (fMRI) Measures; Magnetic Resonance Spectroscopy (MRS)

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 27 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov